Active Trading Blog

The IPOX® Week, July 29, 2019

Solid earnings drive select IPOX Indexes to strong week. IPOX 100 U.S. (ETF: FPX) closes at fresh All-Time High. IPOX-held China Tobacco (6055 HK) adds another +24.09%. IPO Deal-flow Review & Outlook: Healthtech startups Health Catalyst (HCAT US) and Livongo (LVGO US) record strong initial returns. IRONMAN owner Wanda Sports (WSG US) flops. Global IPO.. Read more

The Semiconductors Take Center Stage

By Spencer Israel Earnings season is in full swing, and there are a lot of big names—Apple, Beyond Meat, Pfizer, Twilio, Exxon Mobil, to name a few—reporting this week. But make no mistake: this week belongs to the semiconductors. In fact, this entire year pretty much belongs to the semis. Somehow, despite very little tangible.. Read more

The IPOX® Week, July 22, 2019

Most IPOX Indexes outperform during tough week for U.S. stocks as earnings line up. ETFs in focus: FPX, FPXI and FPXE. China Tobacco Intern. (6055 HK) adds another +17.78%. IPO Deal-flow Review & Outlook: Euphoric U.S. IPO market continues. Goldman Sachs affiliated specialty insurer Prosight (PROS US), IRONMAN owner Wanda Sports (WSG US) inline. Most.. Read more

In 2019, Bad News Is Good And Good News Is…Also Good News

Here are some facts: At 121 months, we are currently in the midst of the longest period of economic expansion in U.S. history. The U.S. yield curve has remained inverted for over a month, a conventional indicator of an oncoming recession. A rate cut at the end of the month is all but guaranteed, as.. Read more

The IPOX® Week, July 15, 2019

Select IPOX Indexes extend gains during quiet trading week. For the 15th time this year, IPOX 100 U.S. (ETF) closes respective trading day at All-Time High. IPO Deal-flow Review & Outlook: Asia Pacific markets led the way in IPO Deal Count last week. “Red-hot” U.S. IPO market set for strong weekly IPO deal flow. Abroad,.. Read more

Try the demo

Compare Platforms
Check the background of this firm on FINRA's BrokerCheck

Our website uses cookies to improve the performance of our site, to analyze the traffic to our site, and to personalize your experience of the site. You can control cookies through your browser settings. Please find more information on the cookies used on our site in our Privacy Policy. By clicking OK, you agree to allow us to collect information through cookies.